Gene: RINL
Official Full Name: Ras and Rab interactor likeprovided by HGNC
Gene Summary: Predicted to enable guanyl-nucleotide exchange factor activity and small GTPase binding activity. Predicted to be involved in endocytosis. Predicted to be located in ruffle. Predicted to be active in cytosol and endocytic vesicle. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27342 | RINL Knockout cell line (HeLa) | Human | RINL | 1:3~1:6 | Negative | Online Inquiry |
KO27343 | RINL Knockout cell line (HCT 116) | Human | RINL | 1:2~1:4 | Negative | Online Inquiry |
KO27344 | RINL Knockout cell line (HEK293) | Human | RINL | 1:3~1:6 | Negative | Online Inquiry |
KO27345 | RINL Knockout cell line (A549) | Human | RINL | 1:3~1:4 | Negative | Online Inquiry |
RINL Gene Knockout Cell Lines are advanced cellular models designed to facilitate the study of gene function and the mechanisms underlying various biological processes. These cell lines have been genetically engineered to permanently deactivate specific genes, thereby providing researchers with invaluable tools for investigating the roles of these genes in health and disease. The knockout process utilizes precision gene-editing techniques, such as CRISPR-Cas9, to ensure high specificity and efficiency.
The key function of RINL Gene Knockout Cell Lines lies in their ability to mimic genetic conditions that can lead to diseases. By observing the phenotypic changes that occur when a specific gene is inactivated, researchers can elucidate the gene’s function, its involvement in signaling pathways, and its potential as a therapeutic target. This product is particularly significant in the realms of cancer research, drug development, and gene therapy, where understanding gene interactions is crucial for creating effective interventions.
One of the unique advantages of RINL Gene Knockout Cell Lines is their user-friendly design, allowing for straightforward experimental setup and reproducibility. Unlike alternative models that may exhibit variability due to off-target effects or incomplete knockouts, RINL cell lines provide a more reliable platform for experimentation, ensuring that results are both actionable and scientifically sound.
Moreover, the pre-characterization of these cell lines facilitates high-throughput screening and validation studies, making them highly valuable to both academic laboratories and clinical research settings. They allow scientists and clinicians to delve deeper into specific pathways and gene networks, ultimately accelerating the pace of discovery in molecular biology and therapeutic development.
At [Your Company Name], we are dedicated to empowering researchers and clinicians by providing cutting-edge biological products, developed with a commitment to quality and innovation. The RINL Gene Knockout Cell Lines epitomize our expertise in gene editing technology, catering to the evolving needs of the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.